Well Care Compounding Pharmacy
Complete recall history across all FDA and CPSC categories — 51 total recalls
Well Care Compounding Pharmacy appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (51)
FDA drug safety enforcement actions by Well Care Compounding Pharmacy. Showing most recent 50.
| Date | Product | Reason | Class |
|---|---|---|---|
| May 17, 2016 | ATROPINE SULFATE 0.5% Ophthalmic Drops, packaged in 5mL droppers, Rx only, We... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | M.I.C. /MB12/B6/DEXPLAN/L-CARN, 25MG/50MG/25MG/10MG/10MG/ML, packaged in 5mL ... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ESTRADIOL VALERATE 20MG/ML, packaged in 5mL vials, Rx only, Well Care Compoun... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 5, packaged in 5 mL vials, Rx only, Well Care Compounding Pharmacy ... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TESTOSTERONE CYPIONATE 10MG/ML, packaged in 5mL vials, Rx only, Well Care Co... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TESTOSTERONE CYPIONATE 100MG/ML, packaged in 5mL vials, Rx only, Well Care C... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TESTOSTERONE CYPIONATE 150MG/ML, packaged in 5mL vials, Rx only, Well Care C... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TESTOSTERONE CYPIONATE 200MG/ML, packaged in 5mL vials, Rx only, Well Care C... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 3, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TESTOSTERONE CYPIONATE 175MG/ML, packaged in 5mL vials, Rx only, Well Care C... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | Hydrogen Peroxide 3%, packaged in 10mL bottles, Rx only, Well Care Compound... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ESTRADIOL VALERATE 40MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | QUAD-MIX #4 (MOD), packaged in 5mL vials, Rx only, Well Care Compounding Phar... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL via... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ESTRADIOL VALERATE 10MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ITRACONAZOLE 0.2%/MUPIROCIN 0.2%/TRIAMCINOLONE 0.03% NASAL SPRAY, 15mL bottle... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | QUAD-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | PHENYLEPHERINE 0.5%, packaged in 5mL vials, Rx only, Well Care Compounding Ph... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | M.l.C. Methyl B12, 25 MG/50MG/25MG/1 MG/ML, packaged in 5mL vials, Rx only, W... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | LEVOCARNITINE 100MG/ML, packaged in 5mL vials, Rx only, Well Care Compoundin... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | 1-HCG 1000 IU/ML, packaged in 5mL and 10mL vials, Rx only, Well Care Compound... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID- 5%/4.75%, packaged in 10mL vials, Rx on... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 6, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | HCG/METHYLCOBALAMIN/FOLIC ACID,1000IU/5MG/0.4MG/ML; packaged in 5 mL vials, R... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | 1-HCG 2000 IU/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharm... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | 17-0H PROGESTERONE 250MG/ML, packaged in 5mL vials, Rx only, Well Care Compou... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | GENTAMICIN 15 MG/ML Ophthalmic Solution, Sterile Droppers, Rx only, Well Care... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | M.l.C./B5/B6 25 MG/50MG/25MG/10MG/10MG/ML, packaged in 5mL vials, Rx only, W... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | METHYLCOBALAMIN/FOLIC ACID; 10MG/0.8MG/ML, packaged in 1mL and 5mL vials, Rx ... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 2, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | M.l.C. 25MG/50MG/25MG/ML, packaged in 5mL vials, Rx only, Well Care Compoun... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | GLUTATHIONE 200MG/ML, packaged in 5mL vials, Well Care Compounding Pharmacy... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | L-GLUT/L-ARG/L-CARN; 25MG/100MG/200MG/ML, packaged in 5mL vials, Rx only, We... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | VANCOMYCIN 50MG/ML OPHTH SOLUTION; packaged in 10mL vial, Rx only, Well Care ... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | VITAMIN B COMPLEX # 3, packaged in 5mL vials, Rx only, Well Care Compoundin... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 4, packaged in 5 mL vials, Rx only, Well Care Compounding Pharmacy ... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | SUPER TRI-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharm... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | VITAMIN B COMPLEX # 1; packaged in 5mL vials, Rx only, Well Care Compoundin... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | METHYLCOBALAMIN 5MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Com... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | CLOTRIMAZOLE 1%/ BETAMETHASONE DIPROPIONATE 0.05% OTIC SOLUTION, 15mL dropper... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | TRI-MIX # 1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ALPHA LIPOIC ACID 25MG/ML, packaged in 5mL vials, Rx only, Well Care Compound... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | SUPER TRI-MIX #4, packaged in 5mL vials, Rx only, Well Care Compounding Pha... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | MYERS' COCKTAIL, packaged in 37 mL vials, Rx only, Well Care Compounding Pha... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | ITRACONAZOLE 0.2%/MUPIROCIN 0.2% NASAL SPRAY; 30 mL Spray, Rx only, Well Car... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | METHYLCOBALAMIN 12.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compound... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | QUAD-MIX #2, packaged in 5mL vial, Rx only, Well Care Compounding Pharmacy La... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | QUAD-MIX #3, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy L... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | METHYLCOBALAMIN 1 MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Co... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
| May 17, 2016 | GLUTATHIONE 100MG/ML, packaged in 10 mL vials, Well Care Compounding Pharmacy... | Lack of Assurance of Sterility: FDA inspection identified GMP violations pote... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.